---
figid: PMC11018795__44321_2024_51_Fig8_HTML
figtitle: Schematic showing the proposed interaction of NAMPT and PD-L1 and their
  dual targeting by LZFPN-90
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11018795
filename: 44321_2024_51_Fig8_HTML.jpg
figlink: /pmc/articles/PMC11018795/figure/Fig8/
number: F8
caption: (Left) Inhibition of PD-1/PD-L1 interactions induces NAMPT expression through
  the HIF-1α/glycolysis pathway. (Middle) Inhibition of NAMPT promotes PD-L1 expression
  by regulating SIRT epigenetics. (Right) LZFPN-90 hinders PD-1/PD-L1 interactions
  and NAMPT activity and affects multiple malignant phenotypes.
papertitle: The regulatory relationship between NAMPT and PD-L1 in cancer and identification
  of a dual-targeting inhibitor.
reftext: Yuan Yang, et al. EMBO Mol Med. 2024 Apr;16(4):885-903.
year: '2024'
doi: 10.1038/s44321-024-00051-z
journal_title: EMBO Molecular Medicine
journal_nlm_ta: EMBO Mol Med
publisher_name: Nature Publishing Group UK
keywords: NAMPT/PD-L1 | Co-targeting Therapy | Cancer | Tumor Immune Microenvironment
  | Metabolism
automl_pathway: 0.9482412
figid_alias: PMC11018795__F8
figtype: Figure
redirect_from: /figures/PMC11018795__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11018795__44321_2024_51_Fig8_HTML.html
  '@type': Dataset
  description: (Left) Inhibition of PD-1/PD-L1 interactions induces NAMPT expression
    through the HIF-1α/glycolysis pathway. (Middle) Inhibition of NAMPT promotes PD-L1
    expression by regulating SIRT epigenetics. (Right) LZFPN-90 hinders PD-1/PD-L1
    interactions and NAMPT activity and affects multiple malignant phenotypes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NAMPT
  - CD274
  - TNF
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - STAC3
  - SNCA
  - SPATA2
  - TNF-a
  - NAD
  - NAMPT
  - NAD+
  - Nucleus
  - PD1
  - Pyruvate
  - Cancer
---
